Publications:24
- Home
- Profiles
Philipp Mews, PhD
- About Me
- Locations
- Publications
- Industry Relationships
About Me
Language
Position
About Me
Language
Position
Locations
Publications
Selected Publications
- Cocaine-induced gene regulation in D1 and D2 neuronal ensembles of the nucleus accumbens. Philipp Mews, Autumn V.A. Mason, Emily G. Kirchner, Molly Estill, Eric J. Nestler. Communications Biology
- Transcriptional characterization of cocaine withdrawal versus extinction within nucleus accumbens in male rats. Freddyson J. Martínez-Rivera, Leanne M. Holt, Angélica Minier-Toribio, Molly Estill, Szu Ying Yeh, Solange Tofani, Rita Futamura, Caleb J. Browne, Philipp Mews, Li Shen, Eric J. Nestler. Nature Communications
- Cocaine and morphine induce shared and divergent transcriptional regulation in nucleus accumbens D1 and D2 medium spiny neurons. Caleb J. Browne, Philipp Mews, Molly Estill, Xianxiao Zhou, Leanne M. Holt, Rita Futamura, Li Shen, Bin Zhang, Eric J. Nestler. Molecular Psychiatry
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Mews during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Founder/Co-Founder/Partner
- Epivario LLC
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Mews during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Founder/Co-Founder/Partner
- Epivario LLC
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.